Day: March 23, 2021
TORONTO, March 23, 2021 (GLOBE NEWSWIRE) — DeFi Technologies Inc. (the “Company” or “DeFi Technologies”) (NEO: DEFI, GR: RMJR) is pleased to announce it has entered into a binding Letter of Intent (“LOI”) to acquire a 80% equity interest in Valour Structured Products, Inc. (“Valour”) from certain shareholders of Valour (“Acquisition”). The Company currently holds a 20% interest in Valour and following the Acquisition, Valour will become a wholly owned subsidiary of DeFi Technologies.
The LOI contemplates that DeFi Technologies and Valour will promptly negotiate and enter into a definitive agreement (“Definitive Agreement”), together with such other documents that may be required in order to formalize and execute the terms of the Acquisition as outlined in the LOI.
Valour Highlights:Bitcoin Zero started trading on December 3rd,...
Troilus to Acquire UrbanGold Minerals in All-Share Transaction
Written by Customer Service on . Posted in Mergers And Acquisitions.
TORONTO, March 23, 2021 (GLOBE NEWSWIRE) — Troilus Gold Corp. (TSX: TLG) (OTCQB: CHXMF) (“Troilus” or the “Company”) and UrbanGold Minerals Inc. (TSXV: UGM) (“UrbanGold”) are pleased to announce that the companies have entered into a definitive agreement (the “Agreement”), pursuant to which Troilus has agreed to acquire all of the issued and outstanding common shares of UrbanGold (the “UrbanGold Shares”) that it does not currently own (the “Transaction”). Troilus currently owns 6,156,291 UrbanGold Shares, or approximately 9.7% of the UrbanGold Shares outstanding. The Transaction is being carried out by way of a three-cornered amalgamation (the “Amalgamation”) under the Canada Business Corporations Act (Canada). UrbanGold shareholders will be asked to vote on the Amalgamation at a special meeting of UrbanGold shareholders (the “UrbanGold...
TELESTE RECORDS A NON-RECURRING ITEM OF EUR 3.2 MILLION IN OTHER OPERATING INCOME
Written by Customer Service on . Posted in Public Companies.
TELESTE CORPORATION INVESTOR NEWS 23 March 2021 at 1.00 pm (EET)
TELESTE RECORDS A NON-RECURRING ITEM OF EUR 3.2 MILLION IN OTHER OPERATING INCOME
Teleste records a non-recurring item of EUR 3.2 million in other operating income in the first quarter of 2021. The income relates to the crime incident announced in March 2019. The company is able to recover EUR 3.2 million as a settlement with insurance companies during the first quarter of 2021 in addition to recovered funds reported in the financial statements of 2019 (recovered funds in total EUR 3.9 million). The company estimates that additional recovery of the funds lost due to the crime incident is unlikely in the future. The company reports the non-recurring income as an adjusted item, which does not affect the adjusted operating profit, nor the financial...
TELESTE KIRJAA KERTALUONTEISEN 3,2 M€ ERÄN LIIKETOIMINNAN MUIHIN TUOTTOIHIN
Written by Customer Service on . Posted in Public Companies.
TELESTE OYJ SIJOITTAJAUUTINEN 23.03.2021 KLO 13:00
TELESTE KIRJAA KERTALUONTEISEN 3,2 M€ ERÄN LIIKETOIMINNAN MUIHIN TUOTTOIHIN
Teleste kirjaa kertaluonteisen 3,2 miljoonan euron erän liiketoiminnan muihin tuottoihin tilikauden 2021 ensimmäisellä neljänneksellä. Tuotto liittyy maaliskuussa 2019 tiedotettuun rikokseen. Aikaisemmin 2019 tilinpäätöksessä raportoidun lisäksi varoja pystytään kuluvan vuosineljänneksen aikana palauttamaan 3,2 miljoonaa euroa korvauksina vakuutusyhtiöiltä (palautukset yhteensä noin 3,9 miljoonaa euroa). Yhtiö pitää epätodennäköisenä, että rikoksen seurauksena menetettyjä varoja pystyttäisiin palauttamaan myöhemmin lisää. Yhtiö raportoi kertaluonteisen tuoton oikaisueränä, joka ei vaikuta oikaistuun liiketulokseen eikä vaikuta yhtiön aikaisemmin tiedottamiin taloudellisiin näkymiin.
TELESTE OYJ
Jukka RinnevaaraToimitusjohtaja
LISÄTIETOJA:...
BioNTech to Report Full Year Financial Results for 2020 and Provide Corporate Update on the Fourth Quarter on March 30, 2021
Written by Customer Service on . Posted in Public Companies.
Mainz, Germany, March 23, 2021 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the fourth quarter 2020 on Tuesday, March 30th, 2021. BioNTech invites investors and the general public to join a conference call and webcast with investment analysts on the same day at 8.00 a.m. EDT (2.00 p.m. CET) to report its financial results and provide a corporate update on the fourth quarter and full year 2020.
The slide presentation and audio of the webcast will be available via the following link: https://edge.media-server.com/mmc/p/j78pn8zg
To participate in the conference call, please dial the following numbers ten minutes prior to the start and provide the Conference ID:United States international:United States domestic (toll-free):Germany:Conference ID:
+1 646 741 3167+1 877...
BioNTech veröffentlicht am 30. März 2021 Ergebnisse des Geschäftsjahres und informiert zum operativen Fortschritt im vierten Quartal 2020
Written by Customer Service on . Posted in Public Companies.
MAINZ, Deutschland, 23. März 2021 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, „BioNTech” oder „das Unternehmen“) wird am Dienstag, den 30. März 2021, die Ergebnisse des vierten Quartals 2020 veröffentlichen. BioNTech wird außerdem am selben Tag um 14.00 Uhr MESZ eine Telefonkonferenz samt Webcast mit Investment-Analysten anbieten, um die Quartalsergebnisse sowie ein Unternehmensupdate für das vierte Quartal und das gesamte Geschäftsjahr 2020 zu präsentieren und lädt Investoren und die allgemeine Öffentlichkeit ein, daran teilzunehmen.
Die Präsentation wird samt Ton über den folgenden Webcast-Link verfügbar sein: https://edge.media-server.com/mmc/p/j78pn8zg
Einwahldaten für die Telefonkonferenz in englischer Sprache:DeutschlandStandard International:Zugangscode:
+49 (0) 692 2222 625+44 (0) 2071 9283384038477Bitte wählen Sie sich...
Emerging Markets Report: Medical Technology Disruptor
Written by Customer Service on . Posted in Public Companies.
An Emerging Markets Sponsored Commentary
ORLANDO, Fla., March 23, 2021 (GLOBE NEWSWIRE) — Medical Technology Disruptor.
Normally, we write our own headlines for the pages of the Emerging Market Report but in this instance there is no finer title than the one that adorns the Company’s homepage. And frankly, it is one of our peak areas of interest.
We’ve been frank about the epic changes that the pandemic has created and our fervent goal to participate in COVID driven trends. There are very few good things about this awful disease but some of the changes in health care for which it has been catalytic are among them. Paramount among them, we believe, will be telehealth and testing enhancements.
As such, let’s take a look at Medivolve Inc. (“Medivolve” or the “Company”) (NEO:MEDV; OTC:COPRF; FRA:4NC)
The company offers investors a...
Emerging Markets Report: A Marriage Made in Manama
Written by Customer Service on . Posted in Public Companies.
An Emerging Markets Sponsored Commentary
ORLANDO, Fla., March 23, 2021 (GLOBE NEWSWIRE) — As rabid fans of the fintech space we are pleased to continue to report on AppTech Corp. (OTC: APCX), a financial technology company utilizing innovative payment processing technologies to complement its core merchant services capabilities. Its patented and proprietary software for merchant services, text marketing and lead generation are licensable or available through a suite of synergistic offerings.
That’s the description from the Company and plainly spoken, AppTech is innovating within Fintech with novel product offerings including a text payment app we reported on previously. Click here to read “A Bright Future for Fintech and FinTEXT”
AppTech Corp. (OTC: APCX) and NEC Payments B.S.C(c) announced on March 08, 2021, the financial closure...
Emerging Markets Report: A Psychedelic Solution to a National Crisis
Written by Customer Service on . Posted in Public Companies.
An Emerging Markets Sponsored Commentary
ORLANDO, Fla., March 23, 2021 (GLOBE NEWSWIRE) — Today’s featured company is emerging in a new lane of health care that we believe could be revolutionary. Please allow us to introduce Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH).
Let’s start with the Company mission statement:
“MINDCURE is focused on finding new ways to treat the profound distress of a world suffering from a mental health crisis. This is a tremendous opportunity to bring a new category of psychoactive and psychedelic treatments to market.”
It’s a bold statement for sure but unless you’ve had your power out the last year you’ve seen the tremendous amount of new interest in psilocybin and psychedelics specifically for mental health applications.
Here are a few bullets to consider before we discuss what’s novel...
Emerging Markets Report: A Tipping Point
Written by Customer Service on . Posted in Public Companies.
An Emerging Markets News Commentary
ORLANDO, Fla., March 23, 2021 (GLOBE NEWSWIRE) — Recent news from U.S.-based restaurant chain operator, Franchisor, and product distributor, Kisses From Italy, Inc. (OTCQB:KITL), begs the obvious question… is the Company at a tipping point?
We come to this question after a lengthy term of service, telling the Kisses story to the market. First we talked about how their offerings caught fire in the home shopping craze over the past year and then their early successes in brick and mortar restaurants.
Both of those separate successes were important, But now they’ve added to it in a way we think is quite significant.
Very recent news confirms that Kisses’ branded products are now in twenty retail locations in Canada. So on top of the robust online sales and award winning franchise operations in the...